# Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics

> **NCT07684274** · — · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 290 (estimated)

## Conditions studied

- Multiple Myeloma (MM)
- Smoldering Multiple Myeloma (SMM)
- MGUS

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07684274
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-13
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 290 (ESTIMATED)
- **Last updated:** 2026-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07684274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07684274, "Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07684274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*